Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Name: Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Published: 2014
License: Public Domain

Amgen · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

arthritis rheumatoid

arthritis, rheumatoid, arthritis, rheumatoid, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Related documents